One of the Mechanisms in Blastic Transformation of Chronic Myeloid Leukemia: Epigenetics Abnormality--Review.
10.7534/j.issn.1009-2137.2016.01.048
- Author:
Zhen MENG
1
;
Ying-Hua LI
2
Author Information
1. Hengshui Harrison International Peace Hospital, Hengshui 053000, Hebei Province, China.
2. Hengshui Harrison International Peace Hospital, Hengshui 053000, Hebei Province, China. E-mail: 1445828799@qq.com.
- Publication Type:Journal Article
- MeSH:
Blast Crisis;
genetics;
Disease Progression;
Epigenesis, Genetic;
Humans;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive;
genetics
- From:
Journal of Experimental Hematology
2016;24(1):250-253
- CountryChina
- Language:Chinese
-
Abstract:
Chronic myeloid leukemia is a myeloproliferative disorder characterized by excessive cloning of bone marrow multipotent stem cells. According to the disease course, the CML may be divided into chronic phase (CP), accelerated phase (AP) and blastic phase (BP). At present, the molecular mechanisms of acute transformation of CML has not been fully understood. The recent studies have shown that the epigenetics is one of mechanisms in blastic transformation of CML, including three molecular mechanisms such as DNA modification, histone modifications and RNA-related dysregulation. The molecular mechanisms for epigenetics leading to the transformation of CML are discussed in this review.
